Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
Des-(N-butyn-1-yl) N-(Buta-1,2-Dien-1-yl) Linagliptin is an impurity in the synthesis of Linagliptin (L465900), a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes.